Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint

Molecular and Cellular Biology

Volumn 16, Issue 12, 1996, Pages 6917-6925

  Lukas, Jiri ^a   Bartkova, Jirina ^a   Bartek, Jiri ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN RECEPTOR; FORSKOLIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MEVALONIC ACID; MEVINOLIN; MITOGENIC AGENT; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RETINOBLASTOMA PROTEIN; THYROTROPIN; THYROTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MAMMAL CELL; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALIA; CANIS FAMILIARIS; MAMMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0029910364     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.12.6917     Document Type: Article

References (73)

1. Ajchenbaum, F., K. Ando, J. A. DeCaprio, and J. D. Griffin. 1993. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J. Biol. Chem. 268:4113-4119.
2. Altucci, L. R. Addeo, L. Cicatiello, S. Dauvois, M. G. Parker, M. Truss, M. Beato, V. Sica, F. Bresciani, and A. Weisz. 17β-estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G1-arrested human breast cancer cells. Oncogene 12:2315-2324.
3. Baldin, V., J. Lukas, M. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-821.
4. Bartek, J., J. Bartkova, and J. Lukas. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol., in press.
5. Bartkova, J., J. Lukas, H. Müller, D. Lützhøft, M. Strauss, and J. Bartek. 1994. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57:353-361.
6. Bates, S., L. Bonetta, D. MacAllan, D. Parry, A. Holder, C. Dickson, and G. Peters. 1994. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene 9:71-79.
7. Bonapace, I. M., R. Addeo, L. Altucci, L. Cicatiello, M. Bifulco, C. Laezza, S. Salzano, V. Sica, F. Bresciani, and A. Weisz. 1996. 17β-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation. Oncogene 12:753-763.
8. Clarke, A. R., E. R. Maandag, M. van Roon, N. M. T. van der Lugt, M. van der Valk, M. L. Hooper, A. Berns, and H. te Riele. 1992. Requirement for a functional RB-1 gene in murine development. Nature (London) 359:328-330.
9. Coats, S., W. M. Flanagan, J. Nourse, and J. M. Roberts. 1996. Requirement of p27 Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877-880.
10. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
11. DeClue, J. E., W. C. Vass, A. G. Papageorge, D. R. Lowy, and B. M. Willumsen. 1991. Inhibition of cell growth by lovastatin is independent of ras function. Cancer Res. 51:712-717.
12. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
13. Dumont, J. A., F. Lamy, P. Roger, and C. Maenhaut. 1992. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol. Rev. 72:667-697.
14. Foster, J. S., and J. Wimalasena. 1996. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol. Endocrinol. 10:488-498.
15. Furlamento, R. W., S. E. Harwell, and K. K. Frick. 1994. Insulin-like growth factor-I induces cyclin D1 expression in MG63 human osteosarcoma cells in vitro. Mol. Endocrinol. 8:510-517.
16. Goodrich, D. W., and W.-H. Lee. 1993. Molecular characterization of the retinoblastoma susceptibility gene. Biochim. Biophys. Acta 1155:43-61.
17. Hall, M., and G. Peters. 1996. Genetic alterations of cycling, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68:67-108.
18. Harper, J. W., and S. J. Elledge. 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:56-64.
19. Heldin, C.-H. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80:213-223.
20. Hengst, L., V. Dulic, J. M. Slingerland, M. Lees, and S. I. Reed. 1994. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91:5291-5295.
21. Hill, C. S., and R. Treisman. 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199-211.
22. Hofmann, F., and D. M. Livingston. 1996. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit. Genes Dev. 10:851-861.
23. Hunter, T., and J. Pines. 1994. Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell 79:573-582.
24. Jacks, T., A. Fazeli, E. M. Schmitt, R. T. Bronson, M. A. Goodell, and R. A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature (London) 359:295-300.
25. Jakobisiak, M., S. Bruno, J. S. Skierski, and Z. Darzynkiewicz. 1991. Cell cycle-specific effects of lovastatin. Proc. Natl. Acad. Sci. USA 88:3628-3632.
26. Kamb, A., N. A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V. Tavtigian, E. Stocken, R S. Day, B. E. Johnson, and M. H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
27. Keyomarsi, K., L. Sandoval, V. Band, and A. B. Pardee. 1991. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res. 51:3602-3609.
28. Kohn, J., G. H. Enders, B. D. Dynlacht, and E. Harlow. 1995. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (London) 375:506-510.
29. Lamy, F., F. Wilkin, M. Baptist, J. Posada, P. R. Roger, and J. E. Dumont. 1993. Phosphorylation of mitogen-activated protein kinases is involved in the EGF and phorbol ester, but not in the thyrotropin/cAMP, thyroid mitogenic pathway. J. Biol. Chem. 268:8398-8401.
30. Lebowitz, P. F., J. P. Davide, and G. C. Prendergast. 1995. Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity. Mol. Cell. Biol. 15:6613-6622.
31. Lee, E. Y.-H., C.-Y. Chang, N. Hu, Y.-C. J. Wang, C.-C. Lai, K. Herrup, W.-H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (London) 359: 288-294.
32. 1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15:3654-3663.
33. 1 control. Cancer Res. 55:4818-4823.
34. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
35. Lukas, J., D. Jadayel, J. Bartkova, E. Nacheva, M. J. S. Dyer, M. Strauss, and J. Bartek. 1994. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. Oncogene 9:2159-2167.
36. Lukas, J., H. Müller, J. Bartkova, D. Spitkovsky, A. A. Kjerulff, P. Jansen-Dürr, M. Strauss, and J. Bartek. 1994. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J. Cell Biol. 125:625-638.
37. Lukas, J., M. Pagano, Z. Staskova, G. Draetta, and J. Bartek. 1994. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9:707-718.
38. Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (London) 375:503-506.
39. INK4-mediated growth suppression. Mol. Cell. Biol. 16:1047-1057.
40. Maltese, W. A. 1990. Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J. 4:3319-3328.
41. Marshall, C. J. 1996. Ras effectors. Curr. Opin. Cell Biol. 8:197-204.
42. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
43. Matsushime, H., M. F. Roussel, R. A. Ashmun, and C. J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701-713.
44. Medema, R. H., R. E. Herrera, F. Lam, and R. A. Weinberg. 1995. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA 92:6289-6293.
45. mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol. Endocrinol. 6:845-854.
46. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077-2086.
47. Migliaccio, A., M. DiDomenico, G. Castoria, A. deFalco, P. Bontempo, E. Nola, and F. Auricchio. 1996. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1292-1300.
48. Musgrove, E. A., J. A. Hamilton, C. S. L. Lee, K. J. E. Sweeney, C. K. W. Watts, and R. L. Sutherland. 1993. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol. 13:3577-3587.
49. Musgrove, E. A., C. S. L. Lee, M. F. Buckley, and R. L. Sutherland. 1994. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA 91:8022-8026.
50. Nevins, J. R. 1992. E2F, a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
51. Pardee, A. B. 1989. G1 events and regulation of cell proliferation. Science 246:603-608.
52. Ink4/MTS1 tumour suppressor gene product. EMBO J. 14:503-511.
53. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
54. Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J.-Y. Kato, D. Bar-Sagi, M. F. Roussel, and C. J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
55. 1/S phase transition by expression of cyclins D1 and E with inducible system. Mol. Cell. Biol. 14:1569-1679.
56. 1-to-S transition. Mol. Cell. Biol. 15:3463-3469.
57. Rivard, N., G. L'Allemain, J. Bartek, and J. Pouyssegur. 1996. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J. Biol. Chem. 271:18337-18341.
58. INK4. Science 267:249-252.
59. Serrano, M., G. J. Hannon, and D. Beach. 1993. A regulatory motif in cell-cycle control causing specific inhibition of cyclin D/cdk4. Nature (London) 366:704-707.
60. Sherr, C. J. 1993. Mammalian G1 cyclins. Cell 73:1059-1065.
61. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
62. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin- dependent kinases. Genes Dev. 9:1149-1163.
63. Strauss, M., J. Lukas, and J. Bartek. 1995. Unrestricted cell cycling and cancer. Nat. Med. 1:1245-1246.
64. Tam, S. W., A. M. Theodoras, J. W. Shay, G. F. Draetta, and M. Pagano. 1994. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with cdk4 is required for cyclin D1 function in G1 progression. Oncogene 9:2663-2674.
65. Watts, C. K. W., A. Brady, B. Sarcevic, A. deFazio, E. A. Musgrove, and R. L. Sutherland. 1995. Antiestrogen inhibition of cell cycle progression in breast cancer cells is associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Mol. Endocrinol. 9:1804-1813.
66. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
67. Wiman, K. G. 1993. The retinoblastoma gene: role in cell cycle control and cell differentiation. FASEB J. 7:841-845.
68. Winston, J. T., S. R. Coats, Y.-Z. Wang, and W.J. Pledger. 1996. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12:127-134.
69. Winston, J. T., and W. J. Pledger. 1993. Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms. Mol. Biol. Cell. 4:1133-1144.
70. Withers, D. J., S. R. Bloom, and E. Rozengurt. 1995. Dissociation of cAMP-stimulated mitogenesis from activation of the mitogen-activated protein kinase cascade in Swiss 3T3 cells. J. Biol. Chem. 270:21411-21419.
71. Won, K. A., Y. Xiong, D. Beach, and M. Z. Gilman. 1992. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. USA 89:9910-9914.
72. Wyke, A. W., M. C. Frame, D. A. F. Gillespie, A. Chudleigh, and J. A. Wyke. 1995. Mitogenesis by v-src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein-kinase responses that parallel the need for the oncoprotein. Cell Growth Differ. 6:1225-1234.
73. Zetterberg, A., O. Larsson, and K. G. Wiman. 1995. What is the restriction point? Curr. Opin. Cell Biol. 7:835-842.